MIM
KERX

MetLife Investment Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

MetLife Investment Management’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-5,191
Closed -$17.6K – 2637
2018
Q3 		$17.6K Sell
5,191
-35,118
-87% -$119K ﹤0.01% 2393
2018
Q2 		$152K Hold
40,309
– – ﹤0.01% 2047
2018
Q1 		$165K Hold
40,309
– – ﹤0.01% 1994
2017
Q4 		$187K Buy
+40,309
New +$187K ﹤0.01% 1965